Skip to content
Join our Newsletter

CEO Ali Tehrani on Zymeworks' US$58m IPO

On the latest show, Cannabis Wheaton CEO Chuck Rifici discusses how his new venture is taking a cue from the mining industry to finance cannabis companies using streaming agreements. Then, Zymeworks CEO Dr.
ali_tehrani_zymeworks
Zymeworks co-founder Ali Tehrani is due to step down as CEO by February 1 | Submitted

On the latest show, Cannabis Wheaton CEO Chuck Rifici discusses how his new venture is taking a cue from the mining industry to finance cannabis companies using streaming agreements.

Then, Zymeworks CEO Dr. Ali Tehrani discusses how his Vancouver life sciences company raised US$58 million through an IPO this month by developing a cancer treatment.

Later, BIV reporter Patrick Blennerhassett discusses the pending pension crisis facing many countries across the globe.

And Attendease CEO Todd Heintz discusses the growing market for online meeting management.

Click here to listen to the show.